Down Modulation of TNF-α mRNA Placental Expression by AZT Used for the Prevention of HIV-1 Mother-to-Child Transmission

Placenta

Volumn 27, Issue 9-10, 2006, Pages 989-995

  Pornprasert, S ^a,b,c   Faye, A ^b,d   Mary, J Y ^d   Dolcini, G ^b   Leechanachai, P ^a   Chaouat, G ^d   Ngo, N ^a   Barre Sinoussi F ^b   Menu, E ^b,d  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b INSTITUT PASTEUR   (France)

^c MAHIDOL UNIVERSITY   (Thailand)

^d INSERM   (France)

Author keywords

AZT; Histoculture; HIV 1; Mother to child transmission; Placental cytokine expression; Prevention

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1ALPHA; STROMAL CELL DERIVED FACTOR 1BETA; TUMOR NECROSIS FACTOR ALPHA; ZIDOVUDINE;

ARTICLE; CHORION VILLUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FETUS; GENE EXPRESSION REGULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFECTION RISK; MICROSCOPY; MORPHOLOGY; PLACENTA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK REDUCTION; UPREGULATION; VERTICAL TRANSMISSION; VIRUS REPLICATION;

ANTI-HIV AGENTS; CHORIONIC VILLI; DISEASE TRANSMISSION, VERTICAL; DOWN-REGULATION; FEMALE; GENE EXPRESSION; HIV INFECTIONS; HIV-1; HUMANS; LIPOPOLYSACCHARIDES; PLACENTA; PREGNANCY; RNA, MESSENGER; TISSUE CULTURE TECHNIQUES; TUMOR NECROSIS FACTOR-ALPHA; ZIDOVUDINE;

EID: 33747155554     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2005.10.010     Document Type: Article

References (40)

1. Connor E.M., Sperling R.S., Gelber R., Kiselev P., Scott G., O'Sullivan M.J., et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 331 (1994) 1173-1180
2. Makokha E.P., Songok E.M., Orago A.A., Koech D.K., Chemtai A.K., Kobayashi N., et al. Maternal immune responses and risk of infant infection with HIV-1 after a short course zidovudine in a cohort of HIV-1 infected pregnant women in rural Kenya. East Afr Med J 79 (2002) 567-573
3. Lallemant M., Jourdain G., Le Coeur S., Kim S., Koetsawang S., Comeau A.M., et al. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med 343 (2000) 982-991
4. Thisyakorn U., Khongphatthanayothin M., Sirivichayakul S., Rongkavilit C., Poolcharoen W., Kunanusont C., et al. Thai Red Cross zidovudine donation program to prevent vertical transmission of HIV: the effect of the modified ACTG 076 regimen. Aids 14 (2000) 2921-2927
5. Thaineua V., Sirinirund P., Tanbanjong A., Lallemant M., Soucat A., and Lamboray J.L. From research to practice: use of short course zidovudine to prevent mother-to-child HIV transmission in the context of routine health care in Northern Thailand. Southeast Asian J Trop Med Public Health 29 (1998) 429-442
6. Mofenson L.M., Lambert J.S., Stiehm E.R., Bethel J., Meyer III W.A., Whitehouse J., et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med 341 (1999) 385-393
7. Alonso Arias R., Gurbindo M.D., Miralles P., Segovia P., Fernandez-Cruz E., and Munoz-Fernandez M.A. Zidovudine treatment prevents vertical transmission of human immunodeficiency virus-1 independently of viral load. Acta Paediatr 87 (1998) 1208-1209
8. Sperling R.S., Shapiro D.E., Coombs R.W., Todd J.A., Herman S.A., McSherry G.D., et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 335 (1996) 1621-1629
9. Liebes L., Mendoza S., Wilson D., and Dancis J. Transfer of zidovudine (AZT) by human placenta. J Infect Dis 161 (1990) 203-207
10. Bawdon R.E., Sobhi S., and Dax J. The transfer of anti-human immunodeficiency virus nucleoside compounds by the term human placenta. Am J Obstet Gynecol 167 (1992) 1570-1574
11. Moussa M., Roques P., Fievet N., Menu E., Maldonado-Estrada J.G., Brunerie J., et al. Placental cytokine and chemokine production in HIV-1-infected women: trophoblast cells show a different pattern compared to cells from HIV-negative women. Clin Exp Immunol 125 (2001) 455-464
12. Zachar V., Hager H., Koppelhus U., Zacharova V., Liu X., Bambra C., et al. Elevated interferon-alpha in maternal and umbilical cord blood and in the placental trophoblast suggests natural protection against vertical transmission of HIV-1 in a Kenyan cohort. Aids 11 (1997) 383-385
13. Lee B.N., Ordonez N., Popek E.J., Lu J.G., Helfgott A., Eriksen N., et al. Inflammatory cytokine expression is correlated with the level of human immunodeficiency virus (HIV) transcripts in HIV-infected placental trophoblastic cells. J Virol 71 (1997) 3628-3635
14. Nair M.P., Sweet A.M., and Schwartz S.A. Immunoregulation of tumor necrosis factor production by HIV-1 gp-120 in neonates and adults. Ann N Y Acad Sci 693 (1993) 309-311
15. Lawn S.D. AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection. J Infect 48 (2004) 1-12
16. Zhao C., Papadopoulou B., and Tremblay M.J. Leishmania infantum promotes replication of HIV type 1 in human lymphoid tissue cultured ex vivo by inducing secretion of the proinflammatory cytokines TNF-alpha and IL-1alpha. J Immunol 172 (2004) 3086-3093
17. Suguitan Jr. A.L., Leke R.G., Fouda G., Zhou A., Thuita L., Metenou S., et al. Changes in the levels of chemokines and cytokines in the placentas of women with Plasmodium falciparum malaria. J Infect Dis 188 (2003) 1074-1082
18. Faye A., Pornprasert S., Dolcini G., Ave P., Taieb J., Taupin J.L., et al. Cytokines and chemokines in placental histocultures. Placenta 26 (2005) 262-267
19. In: Winer B.J. (Ed). Statistical principles in experimental design. 2nd ed. (1971), McGraw-Hill Kogakusha Ltd, Tokyo 514-599
20. O'Sullivan M.J., Boyer P.J., Scott G.B., Parks W.P., Weller S., Blum M.R., et al. The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudine Collaborative Working Group. Am J Obstet Gynecol 168 (1993) 1510-1516
21. Sperling R.S., Roboz J., Dische R., Silides D., Holzman I., and Jew E. Zidovudine pharmacokinetics during pregnancy. Am J Perinatol 9 (1992) 247-249
22. Jaleel M.A., Tsai A.C., Sarkar S., Freedman P.V., and Rubin L.P. Stromal cell-derived factor-1 (SDF-1) signalling regulates human placental trophoblast cell survival. Mol Hum Reprod 10 (2004) 901-909
23. Malassine A., and Cronier L. Hormones and human trophoblast differentiation: a review. Endocrine 19 (2002) 3-11
24. Coulomb-L'Hermine A., Emilie D., Durand-Gasselin I., Galanaud P., and Chaouat G. SDF-1 production by placental cells: a potential mechanism of inhibition of mother-to-fetus HIV transmission. AIDS Res Hum Retroviruses 16 (2000) 1097-1098
25. Polliotti B.M., Gnall-Sazenski S., Laughlin T.S., and Miller R.K. Inhibitory effects of human chorionic gonadotropin (hCG) preparations on HIV infection of human placenta in vitro. Placenta 23 Suppl. A (2002) S102-S106
26. Wu M.Y., Chen H.F., Chen S.U., Chao K.H., Yang Y.S., and Ho H.N. Increase in the production of interleukin-10 early after implantation is related to the success of pregnancy. Am J Reprod Immunol 46 (2001) 386-392
27. Rijhsinghani A.G., Thompson K., Tygrette L., and Bhatia S.K. Inhibition of interleukin-10 during pregnancy results in neonatal growth retardation. Am J Reprod Immunol 37 (1997) 232-235
28. Hennessy A., Pilmore H.L., Simmons L.A., and Painter D.M. A deficiency of placental IL-10 in preeclampsia. J Immunol 163 (1999) 3491-3495
29. Weissman D., Poli G., and Fauci A.S. Interleukin 10 blocks HIV replication in macrophages by inhibiting the autocrine loop of tumor necrosis factor alpha and interleukin 6 induction of virus. AIDS Res Hum Retroviruses 10 (1994) 1199-1206
30. Yang Y., Yelavarthi K.K., Chen H.L., Pace J.L., Terranova P.F., and Hunt J.S. Molecular, biochemical, and functional characteristics of tumor necrosis factor-alpha produced by human placental cytotrophoblastic cells. J Immunol 150 (1993) 5614-5624
31. Osborn L., Kunkel S., and Nabel G.J. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci U S A 86 (1989) 2336-2340
32. Vidricaire G., Tardif M.R., and Tremblay M.J. The low viral production in trophoblastic cells is due to a high endocytic internalization of the human immunodeficiency virus type 1 and can be overcome by the pro-inflammatory cytokines tumor necrosis factor-alpha and interleukin-1. J Biol Chem 278 (2003) 15832-15841
33. Douglas G.C., Hu J., Thirkill T.L., Hovanes K., Sharma S., and King B.F. Effect of cytokines and anti-adhesion molecule antibodies on the adhesion of lymphocytic cells to human syncytiotrophoblast. J Reprod Immunol 27 (1994) 49-62
34. Bacsi A., Csoma E., Beck Z., Andirko I., Konya J., Gergely L., et al. Induction of HIV-1 replication in latently infected syncytiotrophoblast cells by contact with placental macrophages: role of interleukin-6 and tumor necrosis factor-alpha. J Interferon Cytokine Res 21 (2001) 1079-1088
35. Jatczak B., Gejdel E., Pajak J., Podwinska J., and Blach-Olszewska Z. Study on risk factors for transplacental viral infections; effect of bacterial factors and double viral infections on virus replication in placenta and amniotic membranes. Placenta 22 (2001) 360-371
36. Qian M., Bui T., Ho R.J., and Unadkat J.D. Metabolism of 3′-azido-3′-deoxythymidine (AZT) in human placental trophoblasts and Hofbauer cells. Biochem Pharmacol 48 (1994) 383-389
37. Ghosh S.K., Wood C., Boise L.H., Mian A.M., Deyev V.V., Feuer G., et al. Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappa B. Blood 101 (2003) 2321-2327
38. Collier A.C., Helliwell R.J., Keelan J.A., Paxton J.W., Mitchell M.D., and Tingle M.D. 3′-Azido-3′-deoxythymidine (AZT) induces apoptosis and alters metabolic enzyme activity in human placenta. Toxicol Appl Pharmacol 192 (2003) 164-173
39. 2: disparate effects on kinases, NF-{kappa}B, and cytokine expression. Am J Physiol Cell Physiol 286 (2004) C683-C692
40. Byun M.S., Jeon K.I., Choi J.W., Shim J.Y., and Jue D.M. Dual effect of oxidative stress on NF-kappakB activation in HeLa cells. Exp Mol Med 34 (2002) 332-339